Genelex Corporation

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Genelex Corporation sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials none currently recruiting 3 completed upper quartile by trial count

Genelex Corporation: 3 sponsored US clinical trials, none currently recruiting.

Genelex Corporation sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. The most-studied condition in this pipeline is Cytochrome P450 CYP2C19 Enzyme Deficiency, with 1 trials.

Upper-quartile sponsor footprint

Genelex Corporation sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

3 total, page 1 of 1

COMPLETED NA

Pharmacogenetic Testing Among Home Health Patients

NCT02378220
COMPLETED NA

Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM

NCT02428660
COMPLETED

YouScript IMPACT Registry

NCT02191358

Therapeutic Areas

Cytochrome P450 CYP2C19 Enzyme Deficiency 1
Cytochrome P450 CYP2C9 Enzyme Deficiency 1
Extensive Metabolizer Due to Cytochrome P450 CYP2D6 Variant 1
Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant 1
Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant 1
Cytochrome P450 CYP2D6 Enzyme Deficiency 1
CYP2D6 Polymorphism 1
Drug Metabolism, Poor, CYP2C19-Related 1
Drug Metabolism, Poor, CYP2D6-Related 1

How the Genelex Corporation archive is shaped

3 indexed studies, none listed as recruiting (0% open); 3 completed (100%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Cytochrome P450 CYP2C19 Enzyme Deficiency (1 trial), 8 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Genelex Corporation: archived-pipeline peers nationwide

Peers matched on 3 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Genelex Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%0.0%0.0%0.1% Total trials Recruiting share Genelex Corporation10xBio22nd Century GroupAA SecordAAADRS Clinical Research Center23andMe3-C Institute for Social Development3 Waves Wellness3EO Health
Genelex Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Genelex Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Genelex Corporation page

3 registered trials is a research-attention snapshot, not an endorsement of Genelex Corporation or any single study.

  • None of Genelex Corporation's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Cytochrome P450 CYP2C19 Enzyme Deficiency is the condition Genelex Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cytochrome P450 CYP2C19 Enzyme Deficiency trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Genelex Corporation pipeline card: 3 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.